Yellapragada SubbaRow was a pioneering biochemist whose research transformed twentieth-century medicine. After arriving in the United States in 1923, he conducted groundbreaking work at Harvard University, including the development of the Fiske-SubbaRow phosphorus assay and fundamental discoveries in cellular metabolism. As Director of Research at Lederle Laboratories, he led teams that developed folic acid, methotrexate, Aureomycin, and diethylcarbamazine. His scientific leadership helped lay the foundation for modern chemotherapy, antibiotic therapy, and treatments for parasitic diseases, making him one of the most influential biomedical researchers of his era.
